Genmab will sell its non-plasma-derived antibody manufacturing facility, in Brooklyn Park, MN, to Baxter Healthcare for $10m. Baxter will also offer employment to Genmab's employees at the site. Genmab has been trying to sell the facility for a number of years and had written off the value to zero.
Genmab
Monday, 4 March 2013
Genmab finally sells facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment